Monarch Biosciences Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Monarch biosciences inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Monarch Biosciences Inc Today - Breaking & Trending Today

$4.16 Billion Neurovascular Intervention Devices Market - Global Forecast to 2027 - Acquisitions and Partnerships as a Part of the Growth Strategy

Share this article
Share this article
ResearchAndMarkets.com s offering.
The Neurovascular Intervention Devices global market is expected to grow at a high single digit CAGR to reach $4,167.4 million by 2027.
Over the decade, due to the technological advancements with emerging and innovative technologies used under minimally invasive conditions has led to the rapid development of neurovascular interventions. As a result of rapid advances, there is the great expansion in the potential therapeutic application for neurovascular diseases.
Neurovascular Interventional devices are used to treat intracranial aneurysm, ischemic stroke, arteriovenous malformation, carotid stenosis and other diseases like intracranial stenosis, dural fistula. The market is primarily driven by the increase in incidence and prevalence of neurovascular diseases like intracranial aneurysm, stroke and arteriovenous malformations, increase in the aging population, technological advancement, a ....

United States , Deutschland Verwaltungs Gmb , Laura Wood , Cerus Endovascular , Johnson Cerenovus , Medtronic Public Limited Company , Kaneka Pharma America , Ceretrieve Ltd Israel , Artio Medical Inc , Porters Five Force Analysis , Stryker Corporation , Therapeutics Inc , Monarch Biosciences Inc , Cerevasc Inc , Cardinal Health Inc , Office Hours Call , Regulatory Affairs , Research Methodology , Natec Medical Ltd , Jiushi Shenkang Medical Technology China , Sequent Medical Inc , Instylla Inc , Boston Scientific Corporation , Wl Gore Associates , Shape Memory Medical Inc , Microport Scientific Corporation ,

MonarchBio Continues to Build Substantial Thin-Film Nitinol Patent Portfolio

Share this article
Share this article
LOS ANGELES, Jan. 12, 2021 /PRNewswire/ Monarch Biosciences, Inc. (MonarchBio), a California-based life sciences company, announced today that it has recently received Notices of Allowance from the U.S. Patent and Trademark Office (USPTO) for the following U.S. patent applications:
No. 16/298,758 entitled Three-Dimensional Thin-Film Nitinol Devices (U.S. Patent 10,864,096)
No. 16/010,341 entitled Intrasaccular Thin-film Flow Diverters and Related Methods
No. 15/605,754 entitled Thin-Film Cuff for Endothelialization of Endovascular Grafts
No. 16/048,136 entitled Thin-Film Micromesh and Related Methods
Haynes and Boone LLP represented MonarchBio in the successful prosecution of these patent applications and other related applications.
The claims of the patent applications cover the manufacturing of three-dimensional thin-film nitinol (TFN) constructs and include TFN-based intrasaccular flow divert ....

United States , Fred Hutchinson Cancer Research Center , Vikas Gupta , Colin Kealey , Trademark Office , Tini Alloy Company , Monarch Biosciences Inc , Monarch Biosciences , Dimensional Thin Film Nitinol , Thin Film Flow Diverters , Film Cuff , Film Micromesh , Chief Medical Officer , Titan Flow , Vice President , Leon Ekchian , Titan Flow Diverter , United States Federal , Los Angeles Based , Thin Film Nitinol , Tini Alloy , Mayo Clinic , Engineered Lymph Node , Forward Looking Safe Harbor , Health Care Amp Hospitals , Medical Pharmaceuticals ,